SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Sep-24 5:19 PM View: | Eli Lilly & Co. (LLY) | 16-Sep-24 | Grant | 11 | $923.54 | $10,158.90 | < 1% 2.18K to 2.19K | |
05-Aug-24 4:32 PM View: | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 58,876 | -- | -- | (100%) 58.88K to 0 | |
16-Jul-24 4:22 PM View: | Eli Lilly & Co. (LLY) | 15-Jul-24 | Grant | 10 | $950.46 | $9,504.60 | < 1% 2.15K to 2.17K | |
21-Jun-24 3:50 PM View: | Mastercard Inc (MA) | 18-Jun-24 | Grant | 545 | -- | -- | 13% 4.33K to 4.88K | |
11-Jun-24 9:30 PM View: | Warby Parker Inc. (WRBY) | 07-Jun-24 | Grant | 14,793 | -- | -- | 21% 69.23K to 84.02K | |
07-Jun-24 4:28 PM View: | Cerevel Therapeutics Holdin... (CERE) | 05-Jun-24 | Grant | 10,461 | -- | -- | 22% 48.41K to 58.88K | |
21-May-24 4:24 PM View: | Eli Lilly & Co. (LLY) | 20-May-24 | Grant | 13 | $783.18 | $10,181.30 | < 1% 2.13K to 2.14K | |
16-Apr-24 4:14 PM View: | Eli Lilly & Co. (LLY) | 15-Apr-24 | Grant | 13 | $750.77 | $9,760.01 | < 1% 2.12K to 2.13K | |
19-Mar-24 4:23 PM View: | Eli Lilly & Co. (LLY) | 18-Mar-24 | Grant | 13 | $762.66 | $9,914.58 | < 1% 2.1K to 2.12K | |
21-Feb-24 4:26 PM View: | Eli Lilly & Co. (LLY) | 20-Feb-24 | Grant | 13 | $755.66 | $9,823.58 | < 1% 2.08K to 2.1K | |
17-Jan-24 4:19 PM View: | Eli Lilly & Co. (LLY) | 16-Jan-24 | Grant | 16 | $634.57 | $10,153.10 | < 1% 2.07K to 2.08K | |
19-Dec-23 4:16 PM View: | Eli Lilly & Co. (LLY) | 18-Dec-23 | Grant | 9 | $579.76 | $5,217.84 | < 1% 2.06K to 2.07K | |
21-Nov-23 4:30 PM View: | Eli Lilly & Co. (LLY) | 20-Nov-23 | Grant | 343 | $597.60 | $204,977.00 | 20% 1.71K to 2.06K | |
17-Oct-23 4:24 PM View: | Eli Lilly & Co. (LLY) | 16-Oct-23 | Grant | 8 | $616.64 | $4,933.12 | < 1% 1.71K to 1.71K | |
20-Sep-23 4:29 PM View: | Eli Lilly & Co. (LLY) | 18-Sep-23 | Grant | 9 | $571.28 | $5,141.52 | < 1% 1.7K to 1.71K | |
13-Feb-24 10:00 PM View: | Cerevel Therapeutics Holdin... (CERE) | 29-Aug-23 | Gift | 562 | -- | -- | 1% 47.85K to 48.41K | |
22-Aug-23 4:33 PM View: | Eli Lilly & Co. (LLY) | 21-Aug-23 | Grant | 9 | $550.50 | $4,954.50 | < 1% 1.69K to 1.69K | |
18-Jul-23 4:43 PM View: | Eli Lilly & Co. (LLY) | 17-Jul-23 | Grant | 11 | $447.14 | $4,918.54 | < 1% 1.67K to 1.69K | |
29-Jun-23 5:29 PM View: | Mastercard Inc (MA) | 27-Jun-23 | Grant | 642 | -- | -- | 17% 3.69K to 4.33K | |
21-Jun-23 4:28 PM View: | Eli Lilly & Co. (LLY) | 20-Jun-23 | Grant | 11 | $451.95 | $4,971.45 | < 1% 1.66K to 1.67K | |
12-Jun-23 5:38 PM View: | Warby Parker Inc. (WRBY) | 08-Jun-23 | Grant | 23,116 | -- | -- | 50% 46.12K to 69.23K | |
09-Jun-23 4:51 PM View: | Cerevel Therapeutics Holdin... (CERE) | 07-Jun-23 | Grant | 3,282 | -- | -- | 7% 44.57K to 47.85K | |
16-May-23 4:29 PM View: | Eli Lilly & Co. (LLY) | 15-May-23 | Grant | 11 | $434.51 | $4,779.61 | < 1% 1.65K to 1.66K | |
19-Apr-23 4:33 PM View: | Eli Lilly & Co. (LLY) | 17-Apr-23 | Grant | 13 | $372.35 | $4,840.55 | < 1% 1.64K to 1.65K | |
22-Mar-23 4:16 PM View: | Eli Lilly & Co. (LLY) | 20-Mar-23 | Grant | 15 | $333.60 | $5,004.00 | < 1% 1.62K to 1.64K | |
22-Feb-23 4:59 PM View: | Eli Lilly & Co. (LLY) | 21-Feb-23 | Grant | 15 | $327.51 | $4,912.65 | < 1% 1.6K to 1.61K | |
19-Jan-23 4:46 PM View: | Eli Lilly & Co. (LLY) | 17-Jan-23 | Grant | 14 | $357.74 | $5,008.36 | < 1% 1.58K to 1.6K | |
20-Dec-22 5:15 PM View: | Eli Lilly & Co. (LLY) | 19-Dec-22 | Grant | 28 | $357.78 | $10,017.80 | 2% 1.56K to 1.58K | |
22-Nov-22 5:40 PM View: | Eli Lilly & Co. (LLY) | 21-Nov-22 | Grant | 525 | $361.17 | $189,614.00 | 51% 1.03K to 1.55K | |
19-Oct-22 4:24 PM View: | Eli Lilly & Co. (LLY) | 17-Oct-22 | Grant | 30 | $332.76 | $9,982.80 | 3% 1.0K to 1.03K | |
14-Feb-23 10:00 PM View: | Cerevel Therapeutics Holdin... (CERE) | 03-Oct-22 | Gift | 49,624 | -- | -- | (78%) 63.89K to 14.27K | |
21-Sep-22 4:47 PM View: | Eli Lilly & Co. (LLY) | 19-Sep-22 | Grant | 33 | $305.09 | $10,068.00 | 3% 0.97K to 1.0K | |
16-Aug-22 4:27 PM View: | Eli Lilly & Co. (LLY) | 15-Aug-22 | Grant | 32 | $313.94 | $10,046.10 | 3% 0.93K to 0.96K | |
19-Jul-22 8:05 PM View: | Eli Lilly & Co. (LLY) | 18-Jul-22 | Grant | 31 | $321.77 | $9,974.87 | 3% 0.9K to 0.93K | |
28-Jun-22 4:14 PM View: | Cerevel Therapeutics Holdin... (CERE) | 24-Jun-22 | Option Exercise | 14,270 | -- | -- | 29% 49.62K to 63.89K | |
22-Jun-22 5:31 PM View: | Eli Lilly & Co. (LLY) | 21-Jun-22 | Grant | 33 | $297.34 | $9,812.22 | 4% 0.87K to 0.9K | |
23-Jun-22 4:18 PM View: | Mastercard Inc (MA) | 21-Jun-22 | Grant | 741 | -- | -- | 25% 2.95K to 3.69K | |
13-Jun-22 9:01 PM View: | Warby Parker Inc. (WRBY) | 09-Jun-22 | Grant | 16,559 | -- | -- | 56% 29.56K to 46.12K | |
18-May-22 4:42 PM View: | Eli Lilly & Co. (LLY) | 16-May-22 | Grant | 33 | $299.38 | $9,879.54 | 4% 0.83K to 0.86K | |
19-Apr-22 4:29 PM View: | Eli Lilly & Co. (LLY) | 18-Apr-22 | Grant | 33 | $298.82 | $9,861.06 | 4% 0.8K to 0.83K | |
22-Mar-22 4:52 PM View: | Eli Lilly & Co. (LLY) | 21-Mar-22 | Grant | 34 | $289.64 | $9,847.76 | 4% 0.76K to 0.8K | |
24-Feb-22 5:09 PM View: | Eli Lilly & Co. (LLY) | 22-Feb-22 | Grant | 41 | $239.13 | $9,804.33 | 6% 0.72K to 0.76K | |
20-Jan-22 5:27 PM View: | Eli Lilly & Co. (LLY) | 18-Jan-22 | Grant | 40 | $247.07 | $9,882.80 | 6% 0.68K to 0.72K | 5% |
17-Nov-21 4:42 PM View: | Eli Lilly & Co. (LLY) | 15-Nov-21 | Grant | 677 | $258.43 | $174,957.00 | 100% 0 to 0.68K | (< 1%) |
06-Oct-21 9:00 PM View: | Warby Parker Inc. (WRBY) | 04-Oct-21 | Option Exercise | 20,383 | $24.53 | $499,995.00 | 222% 9.17K to 29.56K | |
06-Oct-21 9:00 PM View: | Warby Parker Inc. (WRBY) | 04-Oct-21 | Option Sale | 20,383 | $53.52 | $1,090,900.00 | (69%) 29.56K to 9.17K | |
24-Jun-21 5:32 PM View: | Cerevel Therapeutics Holdin... (CERE) | 24-Jun-21 | Option Exercise | 14,270 | -- | -- | 40% 35.35K to 49.62K | |
24-Jun-21 4:27 PM View: | Mastercard Inc (MA) | 22-Jun-21 | Grant | 622 | -- | -- | 27% 2.33K to 2.95K | |
22-Jun-21 6:31 PM View: | Cerevel Therapeutics Holdin... (CERE) | 17-Jun-21 | Purchase | 21,084 | $13.06 | $275,357.00 | 148% 14.27K to 35.35K | |
01-Jun-21 4:17 PM View: | Brixmor Property Group Inc. (BRX) | 01-Jun-21 | Grant | 5,000 | -- | -- | 16% 32.16K to 37.16K |